Glivec® (Imatinib Mesylate, STI571) in Monotherapy Versus Glivec®-Interferon Alpha in the Treatment of Chronic-Phase Chronic Myeloid Leukaemia

NCT00390897 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

360

Enrollment

OTHER

Sponsor class

Conditions

Chronic Myeloid Leukaemia

Interventions

DRUG: Glivec
DRUG: Interferon

Sponsor

PETHEMA Foundation